TP53 and non-small cell lung carcinoma: Moreover, according to previous studies, this cisplatin exerted its cytotoxic effect which associated with the p53 signaling pathway, and the disturbances in the p53 signaling pathway were associated with NSCLC (Tang et al., 2018a; Tang et al., 2018b).